Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vs Oxytocin in Uniject for PPH Prevention
NCT01710566Phase 3Withdrawn
- Sponsor
- Gynuity Health Projects
- Start
- Jul 2013
- Primary completion
- Dec 2014
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of misoprostol, oxytocin in postpartum hemorrhage (PPH), sponsored by Gynuity Health Projects. Planned start Jul 2013; status: withdrawn.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01710566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710566.